
Search
Selected Filters
Filter Results
Displaying 341–348 of 348 news results
-
Jun 12, 2012
Could Combining Future Treatments Be an Option?
How therapies will likely be used synergistically in the future.
-
May 3, 2012
The FDA's Indispensible Role (a guest blog from Dr. Patricia Zilliox)
While it may not seem obvious, the FDA ultimately drives everything — the researchers and the money. That’s because without FDA approval, you have no treatment, even if you have great research and adequate funding.
-
Apr 11, 2012
There's More Than One Way to Correct a Genetic Defect
A quick primer on genes and their critical role in building proteins.
-
Mar 28, 2012
Vision Testing and Retinal Imaging in Clinical Trials: What Patients Can Expect
Because measuring changes is not always easy, people in clinical trials often undergo a number of different tests over one or several years. It can be challenging for the patient, but is necessary to determine if a treatment is working.
-
Mar 21, 2012
The Importance of Stem Cells (a guest post from Dr. David Gamm)
Dr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
-
Feb 9, 2012
The Foundation's 5 Most Asked Questions About Clinical Trials
What you need to know (and what to expect) about clinical trials.
-
Oct 4, 2011
Gene Therapy Revives Cones Long After They Stop Working
A Foundation-funded research group is developing a gene therapy that revives degenerating cones, enabling them to regain their ability to respond to light and provide vision.
-
Jan 26, 2011
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
- Previous page
- page 1
- …
- page 33
- page 34
- page 35